Why Science Journals Are So Expensive

In 1974, the editorial board of Biochimica et Biophysica Acta, at the time and still the world's largest journal of biochemistry, gathered in Amsterdam to celebrate the journal's 25th anniversary at a lavish party hosted by ier-North Holland Biomedical Press. Attending the gathering were such legendary figures in biochemistry as Sir Hans Krebs, Nobel Prize-winning discoverer of the tricarboxylic acid cycle, Fyodor Lynen, Nobel Prize-winning discoverer of fatty acid synthetase, Alex Bangham, "inv

Written byAlexander Grimwade
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

A recent spate of articles in the press1,2 and of reports from various organizations3 has highlighted once again the difficult problem libraries have with rising journal costs, increasing journal size, and shrinking journal budgets. As the scientific research enterprise has continued to grow, the pressure from scientists to find places to publish their research has grown in parallel. As a result, research journals have continued to proliferate, and the large successful journals have continued to grow in size. Librarians--unable to meet the demands of their clients who want access to a multitude of journals--are crying "uncle" as the commercial publishers have continued to push prices ever higher. What has made matters worse is that it appears to many librarians and scientists, particularly in the United States, that commercial scientific publishing is largely in the hands of relatively few, highly profitable European companies. America, used to being the big dog in ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies